Colorectal cancer detection in the practice setting. Impact of fecal blood testing

D. A. Ahlquist, G. G. Klee, D. B. McGill, R. D. Ellefson

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

To assess the contribution of fecal blood testing to cancer detection in a clinical practice setting, we studied records from 160 patients with both a new tissue diagnosis of colorectal adenocarcinoma and a preceding stool blood test (HemoQuant, Mayo Medical Laboratories, Rochester, Minn) determination. In this group, 71% had suggestive colorectal symptoms (particularly stool changes, overt bleeding, and abdominal pain) or anemia at presentation, and 29% were asymptomatic. Fecal blood levels remained normal in more than 40% of both symptomatic and asymptomatic patients. In only 26 patients (16% overall) was an abnormal fecal blood level the sole heralding feature, but this subset of patients had a more favorable stage. Fecal blood levels were higher with advanced, larger, and more proximal tumors and with stools collected before purgation. We conclude that, in the practice setting, fecal blood level elevation alone is an uncommon but important manner of colorectal cancer presentation, most cancers present with symptoms, and fecal blood levels are often normal in both symptomatic and asymptomatic patients.

Original languageEnglish (US)
Pages (from-to)1041-1045
Number of pages5
JournalArchives of Internal Medicine
Volume150
Issue number5
DOIs
StatePublished - 1990

Fingerprint

Colorectal Neoplasms
Neoplasms
Hematologic Tests
Abdominal Pain
Anemia
Adenocarcinoma
Hemorrhage

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Colorectal cancer detection in the practice setting. Impact of fecal blood testing. / Ahlquist, D. A.; Klee, G. G.; McGill, D. B.; Ellefson, R. D.

In: Archives of Internal Medicine, Vol. 150, No. 5, 1990, p. 1041-1045.

Research output: Contribution to journalArticle

Ahlquist, D. A. ; Klee, G. G. ; McGill, D. B. ; Ellefson, R. D. / Colorectal cancer detection in the practice setting. Impact of fecal blood testing. In: Archives of Internal Medicine. 1990 ; Vol. 150, No. 5. pp. 1041-1045.
@article{fb413a86989b4438921b8d566f4ebeeb,
title = "Colorectal cancer detection in the practice setting. Impact of fecal blood testing",
abstract = "To assess the contribution of fecal blood testing to cancer detection in a clinical practice setting, we studied records from 160 patients with both a new tissue diagnosis of colorectal adenocarcinoma and a preceding stool blood test (HemoQuant, Mayo Medical Laboratories, Rochester, Minn) determination. In this group, 71{\%} had suggestive colorectal symptoms (particularly stool changes, overt bleeding, and abdominal pain) or anemia at presentation, and 29{\%} were asymptomatic. Fecal blood levels remained normal in more than 40{\%} of both symptomatic and asymptomatic patients. In only 26 patients (16{\%} overall) was an abnormal fecal blood level the sole heralding feature, but this subset of patients had a more favorable stage. Fecal blood levels were higher with advanced, larger, and more proximal tumors and with stools collected before purgation. We conclude that, in the practice setting, fecal blood level elevation alone is an uncommon but important manner of colorectal cancer presentation, most cancers present with symptoms, and fecal blood levels are often normal in both symptomatic and asymptomatic patients.",
author = "Ahlquist, {D. A.} and Klee, {G. G.} and McGill, {D. B.} and Ellefson, {R. D.}",
year = "1990",
doi = "10.1001/archinte.150.5.1041",
language = "English (US)",
volume = "150",
pages = "1041--1045",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Colorectal cancer detection in the practice setting. Impact of fecal blood testing

AU - Ahlquist, D. A.

AU - Klee, G. G.

AU - McGill, D. B.

AU - Ellefson, R. D.

PY - 1990

Y1 - 1990

N2 - To assess the contribution of fecal blood testing to cancer detection in a clinical practice setting, we studied records from 160 patients with both a new tissue diagnosis of colorectal adenocarcinoma and a preceding stool blood test (HemoQuant, Mayo Medical Laboratories, Rochester, Minn) determination. In this group, 71% had suggestive colorectal symptoms (particularly stool changes, overt bleeding, and abdominal pain) or anemia at presentation, and 29% were asymptomatic. Fecal blood levels remained normal in more than 40% of both symptomatic and asymptomatic patients. In only 26 patients (16% overall) was an abnormal fecal blood level the sole heralding feature, but this subset of patients had a more favorable stage. Fecal blood levels were higher with advanced, larger, and more proximal tumors and with stools collected before purgation. We conclude that, in the practice setting, fecal blood level elevation alone is an uncommon but important manner of colorectal cancer presentation, most cancers present with symptoms, and fecal blood levels are often normal in both symptomatic and asymptomatic patients.

AB - To assess the contribution of fecal blood testing to cancer detection in a clinical practice setting, we studied records from 160 patients with both a new tissue diagnosis of colorectal adenocarcinoma and a preceding stool blood test (HemoQuant, Mayo Medical Laboratories, Rochester, Minn) determination. In this group, 71% had suggestive colorectal symptoms (particularly stool changes, overt bleeding, and abdominal pain) or anemia at presentation, and 29% were asymptomatic. Fecal blood levels remained normal in more than 40% of both symptomatic and asymptomatic patients. In only 26 patients (16% overall) was an abnormal fecal blood level the sole heralding feature, but this subset of patients had a more favorable stage. Fecal blood levels were higher with advanced, larger, and more proximal tumors and with stools collected before purgation. We conclude that, in the practice setting, fecal blood level elevation alone is an uncommon but important manner of colorectal cancer presentation, most cancers present with symptoms, and fecal blood levels are often normal in both symptomatic and asymptomatic patients.

UR - http://www.scopus.com/inward/record.url?scp=0025263989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025263989&partnerID=8YFLogxK

U2 - 10.1001/archinte.150.5.1041

DO - 10.1001/archinte.150.5.1041

M3 - Article

C2 - 2331185

AN - SCOPUS:0025263989

VL - 150

SP - 1041

EP - 1045

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 5

ER -